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Mesenchymal Stem Cell-Mediated Functional Tooth
Regeneration in Swine
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Mesenchymal stem cell-mediated tissue regeneration is a promising approach for regenerative medicine for a wide range of
applications. Here we report a new population of stem cells isolated from the root apical papilla of human teeth (SCAP, stem
cells from apical papilla). Using a minipig model, we transplanted both human SCAP and periodontal ligament stem cells
(PDLSCs) to generate a root/periodontal complex capable of supporting a porcelain crown, resulting in normal tooth function.
This work integrates a stem cell-mediated tissue regeneration strategy, engineered materials for structure, and current dental
crown technologies. This hybridized tissue engineering approach led to recovery of tooth strength and appearance.
Citation: Sonoyama W, Liu Y, Fang D, Yamaza T, Seo B-M, et al (2006) Mesenchymal Stem Cell-Mediated Functional Tooth Regeneration in Swine. PLoS
ONE 1(1): e79. doi:10.1371/journal.pone.0000079
INTRODUCTION
Regeneration of a functional and living tooth is one of the most
promising therapeutic strategies for the replacement of a diseased
or damaged tooth [1–3]. Recent advances in dental stem cell
biotechnology and cell-mediated murine tooth regeneration have
encouraged researchers to explore the potential for regenerating
living teeth with appropriate functional properties [4–6]. Murine
teeth can be regenerated using many different stem cells to
collaboratively form dental structures in vivo [4,5,7]. In addition,
dentin/pulp tissue and cementum/periodontal complex have been
regenerated by human dental pulp stem cells (DPSCs) and
periodontal ligament stem cells (PDLSCs), respectively, when
transplanted into immunocompromised mice [8,9]. However,
owing to the complexity of human tooth growth and development,
the regeneration of a whole tooth structure including enamel,
dentin/pulp complex, and periodontal tissues as a functional
entity in humans not possible given available regenerative
biotechnologies.
The spatially and temporally organized microenvironment of
the tooth bud and its surrounding tissues permits growth and
development of the crown and roots, resulting in formation and
eruption of the tooth [10]. Root development involves dentin
formation, cementum generation, instruction of epithelium, and
tooth eruption. From a clinical perspective, the most important
part of the tooth is the root which supports for a (natural or
artificial) crown. The crown alone cannot fulfill normal tooth
function without a viable root. In contrast, the wide use of
synthetic crowns to replace a damaged natural crowns has been
widely applied in dental clinics with excellent therapeutic
outcomes [11].
Although dental implant therapies have achieved long-term
success in the clinic for the recovery of tooth function, the dental
implants require pre-existing high-quality bone structures for
supporting the implants [12,13]. Reconstruction of teeth in
patients without adequate bone support would be a major
advance. Stem cell-mediated root regeneration offers opportunities
to regenerate a bio-root and its associated periodontal tissues,
which are necessary for maintaining the physiological function of
teeth. The purpose of this study is to explore the potential for
reconstructing a functional tooth in miniature pigs (minipigs), in
which a bio-root periodontal complex is built up by postnatal stem
cells including stem cells from root apical papilla (SCAP) and
PDLSCs, to which an artificial porcelain crown is affixed. This
hybrid strategy of autologous dental stem cell engineering may be
applicable to human tooth regeneration. Furthermore, functional
tooth restoration in swine may shed light on human tooth
regeneration in the future because of the close similarities between
swine and human dental tissues [14,15].
RESULTS
Isolation and transplantation of SCAP
The mechanism of the contribution of stem progenitors to root
formation remains to be elucidated. Here, we found that human
root apical papilla tissue on the exterior of the root foramen area
demonstrated positive staining for mesenchymal stem cell surface
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molecule STRO-1 (Figure 1A). The root apical papilla might
contain a population of stem/progenitor cells. To identify putative
stem cells, single-cell suspensions were generated from human
root apical papillae collected from extracted third molars of 18–
20 years old adult volunteers, following collagenase/dispase
digestion. When cultured at a low cell density, they formed
adherent clonogenic cell clusters (CFU-F, colony forming unit,
fibroblastic) (Figure 1B), similar to those observed for various
mesenchymal stem cell populations. To investigate the potential of
SCAP to undergo odontoblastic/osteoblastic differentiation,
multiple colony-derived SCAP at passage two were supplemented
with L-ascorbate-2-phosphate, dexamethasone, and inorganic
phosphate to induce mineralization in vitro as described previously
[8,9]. Small round Alizarin Red-positive nodules formed in the
SCAP cultures after four weeks of induction, indicating calcium
accumulation in vitro (Figure 1C). Moreover, cultured SCAP were
capable of differentiating into other cell types such as adipocytes
(Figure 1D), analogous to DPSCs and bone marrow mesenchymal
stem cells (BMMSCs) [8].
To validate the capacity of SCAP to differentiate into functional
dentinogenic cells, ex vivo expanded-SCAP were transplanted into
immunocompromised mice, with hydroxyapatite/tricalcium phos-
phate (HA/TCP) as a carrier. A typical dentin structure was
regenerated, in which a layer of dentin tissue formed on the
surface of the HA/TCP along with connective tissue (Figure 1E).
The newly formed dentin was positive for anti-DSP antibody
staining, and dentin-forming cells stained with anti-human-specific
mitochondria antibody (Figure 1F–H), suggesting that the donor
derived human SCAP had formed the dentin in vivo. In order to
prepare for autologous dental stem cells for functional tooth
regeneration in swine, we isolated single colony-derived swine
SCAP and PDLSCs and transplanted them into immunocompro-
mised mice to regenerate dentin and cementum, respectively
(Figure 1I–1L), equivalent to that of human SCAP and PDLSCs.
We next addressed whether SCAP and DSPCs were the same
or distinct mesenchymal stem cell populations, because both
expressed osteo/odontogenic markers and generate mineralized
tissue when transplanted into immunocompromised mice. First,
Figure 1. Isolation of Stem Cells from Root Apical Papilla (SCAP). (A) Human apical papilla tissue was positive for STRO-1, an early mesenchymal
progenitor marker, staining by immunofluorescence (arrows). (B) Single colonies were formed after human SCAP were plated at a low density (56103/
T25 flask) and cultured for 10 days. (C) When human SCAP were cultured in odontogenic/osteogenic inductive conditions containing L-ascorbate-2-
phosphate, dexamethasone, and inorganic phosphate for 4 weeks, mineralized nodules were found by Alizarin red S staining. (D) Cultured human
SCAP formed Oil red O positive lipid clusters following 5 weeks of adipogenic induction in the presence of 0.5 mM isobutylmethylxanthine, 0.5 mM
hydrocortisone, 60 mM indomethacin, and 10 mg/ml insulin. (E) Eight weeks after transplantation in immunocompromised mice, human SCAP
differentiated into odontoblasts (arrows) that formed dentin (D) on the surfaces of a hydroxyapatite tricalcium (HA) carrier. (F) Immunohistochemical
staining showed that human SCAP differentiated into odontoblasts (arrows) that were positive for anti-human specific mitochondria antibody
staining. (G) Immunohistochemical staining showed that human SCAP-generated dentin (D) was positive for anti-DSP antibody staining (arrows). (H)
Pre-immunoserum negative control of human SCAP transplant. (I) SCAP isolated from swine were capable of forming a single colony cluster when
plated at a low cell density. (J) When transplanted into immunocompromised mice for 8 weeks, swine SCAP differentiate into odontoblasts (arrows)
to regenerate dentin (D) on the surface of the hydroxyapatite carrier (HA). (K) Swine PDLSCs were capable of forming a single colony cluster. (L) After
transplantation into immunocompromised mice, swine PDLSCs formed cementum (C) on the surface of hydroxyapatite carrier (HA). Collagen fibers
were found to connect to newly formed cementum.
doi:10.1371/journal.pone.0000079.g001
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we collected SCAP and DPSCs from the same human tooth and
grew them under exactly same conditions. According to a cDNA
microarray profile comparison (data not shown), there are many
genes differentially expressed between these two stem cell popula-
tions. Among these genes, we selected survivin as one example,
and confirmed its higher expression in SCAP by western blot
(Figure 2A). We also identified that CD 24 as a specific surface
marker of SCAP by flow cytometric analysis (Figure 2B). During
odontogenic differentiation in vitro, SCAP lost the expression of
CD24 with an up-regulated expression of alkaline phosphatase
(ALP) (Figure 3B). In addition, SCAP showed a significantly higher
rate of bromodeoxyuridine (BrdU) uptake (Figure 2C), and
increased number of population doublings (Figure 2D). The
SCAP population also demonstrated an elevated tissue regener-
ation capacity (Figure 2E), higher telomerase activity than that of
DPSCs from the same tooth (Figure 2F), and an improved
migration capacity in a scratch assay (Figure 2G), when compared
to DPSCs from the same tooth. Collectively, these studies sug-
gested that SCAP are a unique population of postnatal stem cells
distinct from DPSC.
Surface molecule characterization of SCAP
To characterize SCAP by surface molecules, we used flow cytome-
tric analysis to demonstrate that SCAP at passage 1 expressed
many surface markers including STRO-1, ALP, CD24, CD29,
CD73, CD90, CD105, CD106, CD146, CD166 and ALP but
were negative for CD34, CD45, CD18 and CD150 (Figure 3A).
STRO-1 and CD146 have been identified as early mesenchymal
stem cell markers present on both BMMSCs and DPSCs [8,16].
Here we found that CD24 appears to be a specific marker for
SCAP, not detectable in other mesenchymal stem cells including
DPSCs and BMMSCs (data not shown). In response to osteogenic
induction conditions in culture, SCAP begin to down regulate
their expression of CD24 while gaining expression of ALP
(Figure 3B). Our experimental evidence suggests that SCAP
derived from a developing tissue may represent a population
of early progenitors that have advantages for use in tissue
regeneration.
Functional tooth regeneration
Identification of SCAP provides an opportunity to pursue root
regeneration using this high-quality ‘‘young’’ postnatal stem cell
derived from 18–20 years old adult vounteers. To play a functional
role in vivo, the root has to connect with the periodontal ligament
to ensure correct positional stability and support in situ. Therefore,
we used both human SCAP and PDLSCs to generate dentin and
PDL on a HA/TCP carrier, in order to mimic a bio-physiological
root/periodontal set-up in vivo. Eight weeks after transplantation,
the human PDLSCs were able to form cementum on the surface of
HA/TCP carrier and Sharpey’s fibers, characterized histologically
Figure 2. Characterization of human SCAP in comparison with DPSCs. (A) Western blot analysis to confirm protein expression of genes identified in
microarray studies showed greater abundance of survivin in SCAP than in DPSCs, with similar levels of DSP and Cbfa1/Runx2. (B) Flow cytometric
analysis showed that ex vivo expanded SCAP contained approximately 7.5% CD24-positive cells, but DPSCs exhibited 0.5% positive staining for CD 24.
(C) The proliferation rates of SCAP and DPSCs, derived from the same tooth, were assessed by co-culture with BrdU for 6 hours. The number of BrdU-
positive cells was presented as a percentage of the total number of cells counted from five replicate cultures. SCAP showed a significantly higher
proliferation rate in comparison with DPSCs (*P=0.0042). (D) Single colony-derived SCAP were able to proliferate to over 70 population doublings,
which was significantly higher than DPSCs (*P= 0.0192). (E) Dentin regeneration capacity of SCAP was significantly higher than that of DPSCs when
transplanted into the same immunocompromised mice (*P=0.0489) using Scion Image analysis system (Scion Image, Rockville, MD). (F) SCAP
showed a significant higher telomerase activity than DPSCs at passage 1 (*P= 0.015). Cultured BMMSCs at passage 1 were used as a negative control
to show an absence of telomerase activity. The telomerase activity was assessed by real time PCR based quantitative telomerase detection kit as
described in Materials and Methods. (G) Cell motility assessed by a scratch assay. A representative area of SCAP and DPSCs at 72 hours after scratch
was presented. Red arrows indicate the ranges of cell migration during 72 hours (*P=0.0033).
doi:10.1371/journal.pone.0000079.g002
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to have collagen fibers anchored into the cementum (Figure 4 A,
B). These data suggested that use of combined mesenchymal stem
cell populations provide a basis for root/periodontal tissue
regeneration.
To accomplish functional tooth regeneration, we used swine
because of the similarities in swine and human orofacial tissue
organization. Swine SCAP were loaded into a root-shaped HA/
TCP block that contained an inner post channel space to allow the
Figure 3. Surface Molecule Characterization of human SCAP. (A) Flow cytometric analysis of cultured SCAP at passage 1 revealed expression of STRO-
1 (18.12%), CD146 (72.3%), CD24 (7.56%), CD166 (93.74%), CD73 (94.14%), CD90 (95.54%), CD105 (9.23%), CD106 (32.7%), CD29 (88.1%) and ALP
(11.43%), but was negative for surface molecules CD18, CD14, CD34, CD45, and CD 150. (B) After 2 weeks osteo-induction in vitro with L-ascorbate-2-
phosphate, dexamethasone, and inorganic phosphate, SCAP differentiated into odontoblasts with a decrease in CD24 expression from 7.56% to
0.22%. In contrast, ALP expression increased significantly from 11.43% to 86.59%.
doi:10.1371/journal.pone.0000079.g003
Figure 4. Comined human SCAP/PDLSC-mediated tissue regeneration. (A) On the outside of the HA/TCP carrier (HA), PDLSCs can form structures
resembling Sharpey’s fibers (arrows) connecting with newly formed cementum (C) on the surface of HA/TCP particles (HA). (B) Immunohistochemical
staining showed that SCAP/PDLSC-generated tissues were positive for human specific mitochondria antibody staining (arrows).
doi:10.1371/journal.pone.0000079.g004
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subsequent installation of a porcelain crown (Figure 5A). A lower
incisor was extracted and the extraction socket was further cleaned
with a surgical bur to remove remaining periodontal tissues
(Figure 5A). The HA/TCP block containing SCAP was coated
with Gelfoam (Pharmacia Canada Inc., Ontario, Canada)
containing PDLSCs and inserted into the socket and sutured for
3 months (Figure 5B–E). CT examination revealed a HA/SCAP-
Gelfoam/PDLSC structure growing inside the socket with
mineralized root-like tissue formation and periodontal ligament
space. The surface of the implanted HA/SCAP-Gelfoam/PDLSC
structure was surgically re-opened at three months post-implan-
tation, and a pre-fabricated porcelain crown resembling a minipig
incisor was inserted and cemented into the pre-formed post
channel inside the HA/TCP block (Figure 5F–H). After suture of
the surgical opening, the porcelain crown was retained in situ and
subjected to the process of tooth function for four weeks (Figure 5I,
J). CT and histologic analysis confirmed that the root/periodontal
structure had regenerated (Figure 5K–M). Moreover, newly
formed bio-roots demonstrated a significantly improved compres-
sive strength than that of original HA/TCP carriers after six-
month implantation (Figure 5N). These findings suggest the
feasibility of using a combination of autologous SCAP/PDLSCs in
conjunction with artificial dental crowns for functional tooth
regeneration.
DISCUSSION
It is generally believed that the dental papilla contributes to tooth
formation and eventually converts to pulp tissue within the pulp
chamber. In this study, we found that the root apical papilla
contained mesenchymal stem cells that appear to have a greater
capacity for dentin regeneration than DPSCs. These findings
suggest that developing tissue may contain a good stem cell
resource for tissue regeneration. SCAP represent a novel popu-
lation of multipotent stem cells as demonstrated by their capacity
to develop into odontoblast-like cells and adipocytes in vitro. This
cell population was found to express high levels of survivin and
telomerase, which are both important molecules in mediating cell
proliferation. In addition, CD24, marker for undifferentiated
SCAP, which is downregulated following odontogenic differenti-
ation. These data support the notion that SCAP are a unique
population of postnatal stem cells.
Although dental pulp contains DPSCs with dentin/pulp
regenerative capacity, developing tissue-derived SCAP showed a
superior tissue regeneration potential than that of DPSCs. SCAP
collected from just one tooth are capable of providing a large
number of stem cells probably sufficient for human transplantation
because they have high proliferative potential, reflected in high
telomerase activity [17]. Human SCAP-mediated tissue regener-
Figure 5. Swine SCAP/PDLSC-mediated root/periodontal structure as an artificial crown support for the restoration of tooth function in swine. (A)
Extracted minipig lower incisor and root-shaped HA/TCP carrier loaded with SCAP. (B) Gelfoam containing 106106 PDLSCs (open arrow) was used to
cover the HA/SCAP (black arrow) and implanted into the lower incisor socket (open triangle). (C) HA/SCAP-Gelfoam/PDLSCs were implanted into
a newly extracted incisor socket. A post channel was pre-created inside the root shape HA carrier (arrow). (D) The post channel was sealed with
a temporary filling for affixing a porcelain crown in the next step. (E) The HA/SCAP-Gelfoam/PDLSC implant was sutured for 3 months. (F) The HA/
SCAP-Gelfoam/PDLSC implant (arrow) was re-exposed and the temporary filling was removed to expose the post channel. (G) A pre-made porcelain
crown was cemented to the HA/SCAP-Gelfoam/PDLSC structure. (H) The exposed section was sutured. (I and J) Four weeks after fixation, the
porcelain crown was retained in the swine after normal tooth use as shown by open arrows. (K) After 3 months implantation, the HA/SCAP-Gelfoam/
PDLSC implant had formed a hard root structure (open arrows) in the mandibular incisor area as shown by CT scan image. A clear PDL space was
found between the implant and surrounding bony tissue (triangle arrows). (L and M) H&E staining showed that implanted HA/SCAP-Gelfoam/PDLSC
contains newly regenerated dentin (D) inside the implant (L) and PDL tissue (PDL) on the outside of the implant (M). (N) Compressive strength
measurement showed that newly formed bio-roots have much higher compressive strength than original HA/TCP carrier (*P= 0.0002), but lower than
that in natural swine root dentin (*P= 0.003) (NR: natural minipig root, BR: newly formed bio-root, HA: original HA carrier).
doi:10.1371/journal.pone.0000079.g005
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ation may offer a promising cell-based therapy for root re-
generation.
Since most human tissue at the developing stage is not clinically
available for stem cell isolation, this apical papilla stem cell
population, accessible in dental clinical practice, is unusual. SCAP
can be isolated from extracted wisdom teeth. Therefore, it may be
possible to bank these high quality dental stem cells for future
autologous use. Their survival in freeze-thawing requires explo-
ration. Allogeneic cells may be another resource of stem cells for
treating those aged individuals who have already have had their
wisdom teeth extracted, however the immunogenicity of these cells
requires further study.
Although newly formed bio-roots show a lower compressive
strength than that of natural swine root dentin, they seemed
capable of supporting porcelain crown and resulted in normal
functions. It may be possible to improve the compressive strength
and hardness of the bio-roots by selecting optimal bioengineered
materials and by optimizing the implanted stem cell numbers and
quality. Stem cell-mediated root regeneration hybridized with
clinical crown technology may be a promising approach for
functional tooth restoration owing to the availability of high-
quality dental stem cells for autologous transplantation as well as
long-term experience with clinical dental implant procedures. In
addition, the orofacial region is an open system for directly
delivering stem cells for tissue engineering. Our studies demon-
strate that minipigs offer an excellent translational model for the
concept of functional tooth regeneration and the feasibility of using
autologous stem cells for transplantation.
MATERIALS AND METHODS
Subjects and Cell Culture
Normal human impacted third molars (n = 18) were collected from
sixteen adults (18–20 yr of age) at the Dental Clinic of the
National Institute of Dental & Craniofacial Research (NIDCR)
under approved guidelines set by NIH Office of Human Subjects
Research and University of Southern California IRB. Root apical
papilla was gently separated from the surface of the root, minced
and digested in a solution of 3 mg/ml collagenase type I
(Worthington Biochemicals Corp., Freehold, NJ) and 4 mg/ml
dispase (Roche Diagnostic/Boehringer Mannheim Corp., India-
napolis, IN) for 30 minutes at 37uC. Single cell suspensions of
SCAP were obtained by passing through a 70 mm strainer (Falcon,
BD Labware, Franklin Lakes, NJ), seeded at 16104 into 10 cm
culture dishes (Costar, Cambridge, MA), and cultured with alpha-
Modification of Eagle’s Medium (GIBCO/Invitrogen, Carlsbad,
CA) supplemented with 15% FBS (Equitech-Bio Inc., Kerrville,
TX), 100 mM L-ascorbic acid 2-phosphate (WAKO, Tokyo,
Japan), 2 mM L-glutamine (Biosource/Invitrogen), 100 U/ml
penicillin and 100 mg/ml streptomycin at 37uC in 5% CO2. To
assess colony-forming efficiency, day 10 cultures were fixed with
4% formalin, and then stained with 0.1% toluidine blue.
Aggregates of $50 cells were scored as colonies. The proliferation
rate of sub-confluent cultures (first passage) of SCAP was assessed
by BrdU incorporation for 6 hours, using BrdU staining Kit
(Zymed/Invitrogen). Conditions for the induction of calcium
accumulation were as reported previously [18]. Calcium accumu-
lation was detected by 2% Alizarin Red S (pH 4.2) staining. The
induction of adipogenesis was as previously reported [8]. DPSCs
and PDLSCs were isolated and cultured as previously described
[8,9]. In some experiments, SCAP, DPSCs, and PDLSCs were
obtained from the same donor or donors. All primary cells used in
this study were at 1–3 passages. For each experiment, same
passage of SCAP, DPSCs, and PDLSCs were used.
Antibodies
Rabbit antibodies included anti-HSP90 (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA); anti-Cbfa1 (EMD Biosciences, Inc., San
Diego, CA); anti-human-specific mitochondria (Chemicon, Teme-
cula, CA). Mouse antibodies included anti-survivin (Santa Cruz
Biotechnology, Inc.); anti-DSP (LF-21) (Dr. Larry Fisher, NIDCR/
NIH); anti-CD146 and STRO-1 (Dr. Stan Gronthos, Institute of
Medical and Veterinary Science, Australia). Rabbit and murine
isotype-matched negative control antibodies were obtained from
Caltag Laboratories (Caltag/Invitrogen). For flow cytometric analy-
sis, R-PE conjugated monoclonal anti-human antibodies include:
CD14, CD18, CD24, CD29, CD34, CD35, CD73, CD90, CD105,
CD106, CD146, CD150, CD166 were purchased from Pharmin-
gen/BD Bioscience (San Jose, CA) and monoclonal anti-human
ALP was from Hybridoma Bank (Iowa University, Iowa).
Transplantation
Approximately 4.06106 of in vitro expanded SCAP, DPSCs, and
PDLSCs were mixed with 40 mg of HA/TCP ceramic particles
(Zimmer Inc, Warsaw, IN) and then transplanted subcutaneously
into the dorsal surface of 10-week-old immunocompromised beige
mice (NIH-bg-nu/nu-xid, Harlan Sprague Dawley, Indianapolis,
IN) as previously described [8,9,18,19]. These procedures were
performed in accordance with specifications of approved animal
protocols (NIDCR #04-317 and USC #10874). The transplants
were recovered after 8 weeks, fixed with 4% formalin, decalcified
with buffered 10% EDTA (pH 8.0), and then embedded in
paraffin. Sections were deparaffinized and stained with H&E.
Immunohistochemistry
Deparaffinized sections were immersed in 3% H2O2/methanol for
15 minutes to quench the endogenous peroxidase activity, and
incubated with primary antibodies (1:200 to 1:500 dilution).
Isotype-matched control antibodies were used under the same
conditions for 1 hour. For enzymatic immunohistochemical
staining, Zymed SuperPicTure polymer detection kit (Zymed/
Invitrogen) was used according to the manufacturer’s protocol.
Subsequently, sections were counterstained with hematoxylin.
Telomerase Activity
Telomerase activity in SCAP, DPSCs and BMSSCs was detected
by using a quantitative telomerase detection kit (Allied Biotech,
Inc., Ijamsville, MD) according to the manufacture’s protocol for
real time PCR. Briefly, the telomerase in the cell extract from
16105 cells of SCAP, DPSCs, or BMSSCs added telomeric
repeats (TTAGGG) onto the 39 end of the substrate oligonucle-
otide and iQ SYBR Green Supermix (BioRad Laboratories,
Hercules, CA), and amplified with an iCycler iQ real-time PCR
machine (BioRad Laboratories). The generated PCR products are
directly detected by measuring the increase in fluorescence caused
by binding of SYBR Green to double-strand DNA and calculated
by using an iCycler iQ software (BioRad Laboratories). Some cell
extract was heated at 85uC for 10 minutes and used for negative
control. The real-time PCR condition was as follows; telomerase
reaction for 20 minutes at 25uC, PCR initial activation step for
3 minutes at 95uC, 3-step cycling; denaturation for 10 seconds at
95uC, annealing for 30 seconds at 60uC, extension for 3 minutes
at 72uC, and cycle number 40 cycles.
Population doubling
SCAP and DPSCs were cultured at low density to form single cell-
derived colonies and then were trypsinized and seeded at a density
Tooth Regeneration
PLoS ONE | www.plosone.org 6 December 2006 | Issue 1 | e79
of 0.56104 cells in 100-mm culture dishes at the first passage.
Upon reaching confluency, the cells were trypsinized and seeded
at the same cell density. The population doubling was calculated at
every passage according to the equation: log2 (the number of
harvested cells/the number of seeded cells). The finite population
doublings were determined by cumulative addition of total
numbers generated from each passage until the cells ceased
dividing [20]. The criteria for cell senescence are that cells do not
divide for a month in culture and that over 60% of the cells are
stained positive for beta-galactosidase [18].
Flow Cytometric Analysis
The procedure for flow cytometric analysis was performed as
described previously [16]. Briefly, cells were trypsinized, and
approximately 26105 cells were pelleted in 5-mL polypropylene
tubes (BD Bioscience). They were treated with 5% heat-
inactivated FBS, 1% BSA (ICN Biomedicals, Inc., Aurora, OH)
and 5% normal human serum (Jackson Immuno Research
Laboratories, Inc., West Grove, PA) in HBSS (GIBCO/Invitro-
gen) for 30 minutes on ice to block non-specific binding sites. For
STRO-1 and ALP staining, some of the cells were incubated with
100 ml of STRO-1 supernatant (mouse IgM anti-human STRO-1)
[16] or mouse IgG1 anti-human bone/liver/kidney ALP (Hybrid-
oma Bank) for 45 minutes on ice. After washing with 5% heat-
inactivated FBS in HBSS at 4uC, they were reacted with R-PE
conjugated goat F(ab9)2 anti-mouse IgM (m chain specific)
(Biosource/Invitrogen) or anti-mouse IgG (H+L) (Southern Bio-
technology Associates, Inc., Birmingham, AL) for 30 minutes on
ice. For CD24 staining, the cells were treated with 1 mg of R-PE
conjugated mouse IgG1 anti-mouse CD24 (BD Bioscience) for
45 minutes on ice. As negative controls, some of the cells were
incubated with 1 mg of non-immune mouse IgM (Southern
Biotechnology Associates, Inc.) or IgG1 (BD Bioscience). After
washing, all of the cells were then sorted on a FACSCalibur flow
cytometer (BD Bioscience) by collecting 10,000 events, and
analyzed by means of a Cell Quest software (BD Bioscience).
Swine Model
Six inbred male minipigs (4–8 month-old, weighing 20–40 kg)
were obtained from the Institute of Animal Science of the Chinese
Agriculture University. At this age, minipig incisors are still
developing. Minipigs were kept under conventional conditions
with free access to water and regularly supply of soft food. This
study was reviewed and approved by the Animal Care and Use
Committees of Capital University of Medical Sciences and the
Institute of Dental and Craniofacial Research. Minipigs were
anaesthetized with a combination of ketamine chloride (6 mg/kg)
and xylazine (0.6 mg/kg) before the surgery. Minipig SCAP and
PDLSCs were isolated and cultured the same as human SCAP and
PDLSCs as mentioned above.
Western Blotting
Primary antibodies were used at dilutions ranging from 1:200 to
1:1000. Western blot analyses were carried out as previously
reported [18,21].
Compressive Strength Measurement
Compressive strength was tested by H5KS type force test system
with loading of 1mm/min (Tinius Olsen H5KS testing machine,
Tinius Olsen, Ltd., Survey, UK). A newly formed bio-root was
harvested six months after transplant, and divided into three
pieces. Compressive strength of each piece was measured
separately. Compressive strength of natural minipig roots and
original HA/TCP carriers were also measured (n= 5, each group).
Statistical Analysis
Student t-test was used to analyze the differences between groups.
One-way repeated ANOVA followed by Scheffe’s comparison was
used to compare data from three or more groups. P values less
than 0.05 were considered as statistically significant. All statistical
data are presented as mean6SD (n= 5).
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